Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian CancerEmanuele Perrone, Alessandro D. Santin|Frontiers in Oncology|2020Cited by 60
Concurrent endometrial cancer in atypical endometrial hyperplasia and the role of sentinel lymph nodes: clinical insights from a multicenter experienceAndrea Rosati, Francesco Fanfani, Vito Andrea Capozzi et al.|International Journal of Gynecological Cancer|2024Cited by 10